HIF1A and prostate carcinoma: Furthermore, Peng et al. identified a marine-derived HIF1A inhibitor, Yardenone 2, which suppresses the proliferation of prostate cancer cells by reducing HIF1A nuclear localization at the protein level (Peng et al., 2024).